The Clinical Trials of Mesenchymal Stromal Cells Therapy

Mesenchymal stromal cells (MSCs) are a heterogeneous population of adult stem cells, which are multipotent and possess the ability to differentiate/transdifferentiate into mesodermal and nonmesodermal cell lineages. MSCs display broad immunomodulatory properties since they are capable of secreting g...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mohammad Reza Kouchakian, Neda Baghban, Seyedeh Farzaneh Moniri, Mandana Baghban, Shabnam Bakhshalizadeh, Vahid Najafzadeh, Zahra Safaei, Safoura Izanlou, Arezoo Khoradmehr, Iraj Nabipour, Reza Shirazi, Amin Tamadon
Formato: article
Lenguaje:EN
Publicado: Hindawi Limited 2021
Materias:
Acceso en línea:https://doaj.org/article/7b7c59fb4f8b461bbc8628c87e2dbd7e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7b7c59fb4f8b461bbc8628c87e2dbd7e
record_format dspace
spelling oai:doaj.org-article:7b7c59fb4f8b461bbc8628c87e2dbd7e2021-11-15T01:19:57ZThe Clinical Trials of Mesenchymal Stromal Cells Therapy1687-967810.1155/2021/1634782https://doaj.org/article/7b7c59fb4f8b461bbc8628c87e2dbd7e2021-01-01T00:00:00Zhttp://dx.doi.org/10.1155/2021/1634782https://doaj.org/toc/1687-9678Mesenchymal stromal cells (MSCs) are a heterogeneous population of adult stem cells, which are multipotent and possess the ability to differentiate/transdifferentiate into mesodermal and nonmesodermal cell lineages. MSCs display broad immunomodulatory properties since they are capable of secreting growth factors and chemotactic cytokines. Safety, accessibility, and isolation from patients without ethical concern make MSCs valuable sources for cell therapy approaches in autoimmune, inflammatory, and degenerative diseases. Many studies have been conducted on the application of MSCs as a new therapy, but it seems that a low percentage of them is related to clinical trials, especially completed clinical trials. Considering the importance of clinical trials to develop this type of therapy as a new treatment, the current paper is aimed at describing characteristics of MSCs and reviewing relevant clinical studies registered on the NIH database during 2016-2020 to discuss recent advances on MSC-based therapeutic approaches being used in different diseases.Mohammad Reza KouchakianNeda BaghbanSeyedeh Farzaneh MoniriMandana BaghbanShabnam BakhshalizadehVahid NajafzadehZahra SafaeiSafoura IzanlouArezoo KhoradmehrIraj NabipourReza ShiraziAmin TamadonHindawi LimitedarticleInternal medicineRC31-1245ENStem Cells International, Vol 2021 (2021)
institution DOAJ
collection DOAJ
language EN
topic Internal medicine
RC31-1245
spellingShingle Internal medicine
RC31-1245
Mohammad Reza Kouchakian
Neda Baghban
Seyedeh Farzaneh Moniri
Mandana Baghban
Shabnam Bakhshalizadeh
Vahid Najafzadeh
Zahra Safaei
Safoura Izanlou
Arezoo Khoradmehr
Iraj Nabipour
Reza Shirazi
Amin Tamadon
The Clinical Trials of Mesenchymal Stromal Cells Therapy
description Mesenchymal stromal cells (MSCs) are a heterogeneous population of adult stem cells, which are multipotent and possess the ability to differentiate/transdifferentiate into mesodermal and nonmesodermal cell lineages. MSCs display broad immunomodulatory properties since they are capable of secreting growth factors and chemotactic cytokines. Safety, accessibility, and isolation from patients without ethical concern make MSCs valuable sources for cell therapy approaches in autoimmune, inflammatory, and degenerative diseases. Many studies have been conducted on the application of MSCs as a new therapy, but it seems that a low percentage of them is related to clinical trials, especially completed clinical trials. Considering the importance of clinical trials to develop this type of therapy as a new treatment, the current paper is aimed at describing characteristics of MSCs and reviewing relevant clinical studies registered on the NIH database during 2016-2020 to discuss recent advances on MSC-based therapeutic approaches being used in different diseases.
format article
author Mohammad Reza Kouchakian
Neda Baghban
Seyedeh Farzaneh Moniri
Mandana Baghban
Shabnam Bakhshalizadeh
Vahid Najafzadeh
Zahra Safaei
Safoura Izanlou
Arezoo Khoradmehr
Iraj Nabipour
Reza Shirazi
Amin Tamadon
author_facet Mohammad Reza Kouchakian
Neda Baghban
Seyedeh Farzaneh Moniri
Mandana Baghban
Shabnam Bakhshalizadeh
Vahid Najafzadeh
Zahra Safaei
Safoura Izanlou
Arezoo Khoradmehr
Iraj Nabipour
Reza Shirazi
Amin Tamadon
author_sort Mohammad Reza Kouchakian
title The Clinical Trials of Mesenchymal Stromal Cells Therapy
title_short The Clinical Trials of Mesenchymal Stromal Cells Therapy
title_full The Clinical Trials of Mesenchymal Stromal Cells Therapy
title_fullStr The Clinical Trials of Mesenchymal Stromal Cells Therapy
title_full_unstemmed The Clinical Trials of Mesenchymal Stromal Cells Therapy
title_sort clinical trials of mesenchymal stromal cells therapy
publisher Hindawi Limited
publishDate 2021
url https://doaj.org/article/7b7c59fb4f8b461bbc8628c87e2dbd7e
work_keys_str_mv AT mohammadrezakouchakian theclinicaltrialsofmesenchymalstromalcellstherapy
AT nedabaghban theclinicaltrialsofmesenchymalstromalcellstherapy
AT seyedehfarzanehmoniri theclinicaltrialsofmesenchymalstromalcellstherapy
AT mandanabaghban theclinicaltrialsofmesenchymalstromalcellstherapy
AT shabnambakhshalizadeh theclinicaltrialsofmesenchymalstromalcellstherapy
AT vahidnajafzadeh theclinicaltrialsofmesenchymalstromalcellstherapy
AT zahrasafaei theclinicaltrialsofmesenchymalstromalcellstherapy
AT safouraizanlou theclinicaltrialsofmesenchymalstromalcellstherapy
AT arezookhoradmehr theclinicaltrialsofmesenchymalstromalcellstherapy
AT irajnabipour theclinicaltrialsofmesenchymalstromalcellstherapy
AT rezashirazi theclinicaltrialsofmesenchymalstromalcellstherapy
AT amintamadon theclinicaltrialsofmesenchymalstromalcellstherapy
AT mohammadrezakouchakian clinicaltrialsofmesenchymalstromalcellstherapy
AT nedabaghban clinicaltrialsofmesenchymalstromalcellstherapy
AT seyedehfarzanehmoniri clinicaltrialsofmesenchymalstromalcellstherapy
AT mandanabaghban clinicaltrialsofmesenchymalstromalcellstherapy
AT shabnambakhshalizadeh clinicaltrialsofmesenchymalstromalcellstherapy
AT vahidnajafzadeh clinicaltrialsofmesenchymalstromalcellstherapy
AT zahrasafaei clinicaltrialsofmesenchymalstromalcellstherapy
AT safouraizanlou clinicaltrialsofmesenchymalstromalcellstherapy
AT arezookhoradmehr clinicaltrialsofmesenchymalstromalcellstherapy
AT irajnabipour clinicaltrialsofmesenchymalstromalcellstherapy
AT rezashirazi clinicaltrialsofmesenchymalstromalcellstherapy
AT amintamadon clinicaltrialsofmesenchymalstromalcellstherapy
_version_ 1718428930402156544